1253799-61-9

Basic information

• Product Name: 3-(benzyloxy)-5-chloroisonicotinic acid
• Synonyms: 3-(benzyloxy)-5-chloroisonicotinic acid
• CAS NO: 1253799-61-9
• Molecular Weight: 263.68
• Mol File: 1253799-61-9.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 3-(benzyloxy)-5-chloroisonicotinic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(benzyloxy)-5-chloroisonicotinic acid(1253799-61-9)
• EPA Substance Registry System: 3-(benzyloxy)-5-chloroisonicotinic acid(1253799-61-9)

Safety Data

• Hazardous Substances Data: 1253799-61-9(Hazardous Substances Data)

Upstream product

• 13958-93-5 3,5-dichloropyridine-4-carboxylic acid 
• 100-51-6 benzyl alcohol 

Downstream Products

• 1254367-42-4 phenyl 3-(benzyloxy)-2-bromo-6-chloro-5-methylisonicotinate 
• 1254367-43-5 C₂₀H₁₇NO₄ 
• 1254367-50-4 phenyl 5-(benzyloxy)-2-methoxy-3-methylisonicotinate 
• 1254367-39-9 phenyl 5-(benzyloxy)-2-(dimethylamino)-3-methylisonicotinate 
• 1254367-63-9 phenyl 5-benzyloxy-2-(dimethylamino)-3-methyl-6-(propylamino)isonicotinate 
• 1254367-58-2 (4aS,11aR,12aS,13S)-10-chloro-13-(dimethylamino)-4a-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-8-(ethylamino)11a,12,12a,13-tetrahydro-5-hydroxy-3,7-bis(phenylmethoxy)-isoxazolo[5',4':6,7]naphth[2,3-g]-isoquinoline-4,6(4aH,11H)-dione 
• 1268248-39-0 N-[(4aS,11aR,12aS,13S)-10-chloro-13-(dimethylamino)-4a-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-4,4a,6,11,11a,12,12a,13-octahydro-5-hydroxy-4,6-dioxo-3,7-bis(phenylmethoxy)isoxazolo[50,40:6,7]naphth[2,3-g]isoquinolin-8-yl]-2-[(1,1-dimethylethyl)amino]-acetamide 
• 1254367-67-3 C₂₅H₂₅BrN₂O₅ 
• 1254367-66-2 phenyl 3-(benzyloxy)-2-bromo-6-[(t-butoxycarbonyl)-amino]-5-methylisonicotinate 
• 1254367-38-8 phenyl 5-(benzyloxy)-2-bromo-3-methylisonicotinate 
• 1254367-94-6 (4aS,11aR,12aS,13S)-10,13-bis(dimethylamino)-4a-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-11a,12,12a,13-tetrahydro-5-hydroxy-3,7-bis(phenylmethoxy)-8-(2-propen-1yl)-isoxazolo[5',4':6,7]naphth[2,3-g]isoquinoline-4,6(4aH,11H)-dione 
• 1254367-41-3 phenyl 5-(benzyloxy)-2-chloro-3-methylisonicotinate 
• 1254368-84-7 C₂₀H₁₆ClNO₃ 
• 1253799-65-3 phenyl 3-(benzyloxy)-5-methylisonicotinate 

Relevant articles and documents

NITROGEN-CONTAINING HETEROCYCLIC COMPOUND

Provided is a compound having a cholinergic muscarinic M1 receptor positive allosteric modulator activity, and useful as a prophylactic or therapeutic drug for Alzheimer's disease, schizophrenia, pain, sleep disorder and the like. The present invention relates to a compound represented by the formula wherein ring A is a 4- to 7-membered ring optionally having substituent (s) ; L is -O-, -S-, -SO- or -SO2-; R1 is a C1-6 alkyl group optionally having substituent(s) (provided that when L is -O-, R1 is not a C1-6 alkyl group optionally substituted by halogen atom(s)), or a cyclic group optionally having substituent(s); X1 is -CRa= or -N=; X2 is -CRb= or -N=; X3 is-CRc= or -N=; Ra, Rb and Rc are each a C1-6 alkyl group, C2-6 alkenyl group, C1-6 alkoxy group, C3-6 cycloalkyl group, C3-6 cycloalkoxy group or C6-14 aryl group, each of which optionally having substituent(s), H or halogen, or a salt thereof.

8-AZA TETRACYCLINE COMPOUNDS

The present invention is directed to a compound represented by Structural Formula (I) or a pharmaceutically acceptable salt thereof. The variables for Structural Formula I are defined herein. Also described is a pharmaceutical composition comprising the compound of Structural Formula I and its therapeutic use.